Beta Bionics Income Statement (2023-2025) | BBNX

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 12.93M15.05M16.70M20.44M17.64M23.24M27.25M
Cost of Revenue 7.66M8.97M9.64M10.80M13.40M15.62M16.05M
Gross Profit 7.20M8.08M8.91M11.69M8.97M12.50M15.12M
Operating items
Research & Development 5.48M6.35M5.14M9.21M7.59M8.87M8.20M
Selling, General & Administrative 3.51M4.54M5.11M4.71M6.62M7.88M7.92M
Other Operating Expenses 7.66M8.97M9.64M10.80M13.40M15.62M16.05M
Operating Expenses 16.65M19.87M19.89M24.73M27.61M32.38M32.16M
Operating Income -9.45M-11.78M-10.98M-13.04M-18.64M-19.87M-17.04M
EBIT -9.45M-11.78M-10.98M-13.04M-18.64M-19.87M-17.04M
Non-operating items
Interest & Investment Income 1.14M0.99M0.83M0.95M2.44M3.00M2.83M
Other Non Operating Income 0.00M-0.00M-0.00M-0.00M0.00M
Non Operating Income -3.00M-2.68M1.24M-5.07M-10.01M3.00M2.83M
Net income details
EBT -8.31M-10.79M-10.15M-12.09M-16.21M-16.87M-14.21M
Profit After Tax -12.45M-14.46M-9.74M-18.11M-28.66M-16.87M-14.21M
Income from Continuing Operations -8.31M-10.79M-10.15M-12.09M-16.21M-16.87M-14.21M
Consolidated Net Income -8.31M-10.79M-10.15M-12.09M-16.21M-16.87M-14.21M
Income towards Parent Company -8.31M-10.79M-10.15M-12.09M-16.21M-16.87M-14.21M
Net Income towards Common Stockholders -8.31M-10.79M-10.15M-12.09M-16.21M-16.87M-14.21M
Additional items
EPS (Basic) -2.07-2.37-1.46-1.90-0.93-0.39-0.33
EPS (Weighted Average and Diluted) -2.07-2.37-1.46-1.90-0.93-0.39-0.33
Shares Outstanding (Weighted Average) 5.30M6.02M6.11M6.66M6.37M30.71M43.39M43.63M
Shares Outstanding (Diluted Average) 5.30M6.02M6.11M6.66M6.37M30.71M43.39M43.63M
EBITDA -12.58M-14.49M-9.66M-18.10M-28.48M-16.96M-14.00M